Development of industrial biocatalysts and therapeutic polypeptides by protein engineering (Q3712427): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3776191 / rank | |||
Normal rank | |||
Revision as of 19:17, 24 November 2021
Project Q3712427 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of industrial biocatalysts and therapeutic polypeptides by protein engineering |
Project Q3712427 in France |
Statements
1,583,958.57 Euro
0 references
2,828,497.44 Euro
0 references
56.0 percent
0 references
17 June 2016
0 references
31 December 2019
0 references
SAS PEACCEL
0 references
Le projet de la société « PEACCEL » consiste au développement et à l'optimisation d'une plateforme virtuelle permettant d'effectuer la synthèse de molécules à destination de secteurs de la pharmaceutique, de l'agroalimentaire, du biogaz,… (French)
0 references
The project of the company “PEACCEL” consists of the development and optimisation of a virtual platform enabling the synthesis of molecules for the pharmaceutical, agri-food, biogas sectors, etc. (English)
22 November 2021
0 references
Identifiers
RE0006507
0 references